Abstract MHC class II molecules including HLA-DR present peptide fragments from proteins degraded in the endocytic pathway. HLA-DR is targeted to late endocytic structures named MIIC where it interacts with HLA-DM. This chaperone stabilizes HLA-DR during peptide exchange, and is critical for successful peptide loading. To follow this process in living cells, we have generated cells containing HLA-DR3/CFP, HLA-DM/YFP and invariant chain. HLA-DR/DM interactions were observed by FRET. These interactions were pH insensitive, yet occurred only in internal structures and not at the limiting membrane of MIIC. In a cellular model of infection, phagosomes formed a limiting membrane surrounding internalized Salmonella. HLA-DR and HLA-DM did not interact in Salmonella-induced vacuoles, and HLA-DR was not loaded with antigens. The absence of HLA-DR/ DM interactions at the limiting membrane prevents local loading of MHC class II molecules in phagosomes. This may allow these bacteria to successfully evade the immune system.
Spacial Separation of HLA-DM/HLA-DR Interactions within MIIC and PhagosomeInduced Immune Escape Immunity 2005, vol. 22:221-233 Introduction MHC class II molecules present peptide fragments of antigens degraded in the endocytic pathway to CD4+ T cells (Bryant et al., 2002) . This is a prerequisite for efficient antibody responses and the establishment of an effective immunological memory. In order to contact antigens, MHC class II molecules like HLA-DR (DR) are chaperoned from the endoplasmic reticulum (ER) to late endocytic structures (called MHC class II containing compartments, or MIIC (Peters et al., 1991) ) by the invariant chain. Here, the invariant chain is degraded, except for a small fragment called CLIP, which remains in the peptide-binding groove of DR (Cresswell, 1992) . HLA-DM (DM), a second dedicated chaperone, is required to stabilize the 'empty' MHC class II molecules and supports the exchange of both CLIP and low affinity peptides for a peptide with high affinity (Denzin and Cresswell, 1995; Kropshofer et al., 1997; Sherman et al., 1995) that fills pocket 1 in the peptide binding groove (Chou and Sadegh-Nasseri, 2000) . The direct interaction between DM and DR has been shown in in vitro reconstitution experiments and co-isolations. This interaction was pH sensitive and of low affinity Vogt et al., 1999) . DM interacts with a lateral site on DR via hydrophobic surfaces, but the exact factors that contribute to this process remain unclear (Doebele et al., 2000; Pashine et al., 2003; Ullrich et al., 1997) . More recently, a non-polymorphic MHC class II homologue has been identified, called HLA-DO (DO). DO stably interacts with DM, reducing its chaperoning activity on DR in a pH-dependent manner (Denzin et al., 1997; Liljedahl et al., 1998; van Ham et al., 1997) . Like the DR/ DM complex, the DM/DO complex is targeted to the MIIC.
MIIC are characterized by a multilamellar and/or multivesicular structure. Multivesicular bodies (MVB) can be converted into multilamellar structures by changes in protein content and both type of structures most likely reflect different maturation states (Kleijmeer et al., 1997) . The internal structures differ from the limiting membrane by both protein and lipid composition. Whereas DR and DM can be found in both domains, other late endocytic proteins like tetraspans, and lipids like cholesterol and lyso-bis-PA, are usually located at the internal structures (Gruenberg, 2003; Wubbolts et al., 2003) . Although tetraspans like CD63 and CD82 interact with DM or DR (Escola et al., 1998; Hammond et al., 1998) , the functional consequences are unclear. Still, internal structures differ in composition from the limiting membrane, and this may affect the interaction between DR and its chaperone DM, and ultimately antigen pre-
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Chapter 10 | HLA-DM/-DR interactions in vivo sentation (Kropshofer et al., 2002) . The failure to visualize these interactions due to the limited resolution of light microscopy prevented any conclusion about spatial specialization within MIIC.
The formation of internal structures that characterize the morphology of a MVB is the result of a complicated series of events. It requires the activities of a PI 3-kinase hVPS34, ESCRT complexes, ubiquitination and acidification (Katzmann et al., 2002) . Inhibition of hVPS34 or acidification results in expanded late endosomal structures without internal vesicles (Fernandez-Borja et al., 1999) . Such treatments also affect the MIIC, and inhibit antigen presentation by MHC class II molecules (Morrison et al., 1986; Song et al., 1997) . Pathogens like Salmonella typhimurium, Mycobacterium tuberculosis, and Mycobacterium leprae survive in phagosomes (Brumell and Grinstein, 2004; Russell, 2003) , structures composed of only a limiting membrane surrounding the bacteria. These intracellular bacteria have been reported to reduce or even eliminate antigen presentation by MHC class II molecules (Harding et al., 2003; Ramachandra et al., 2001; Ullrich et al., 2000) , but the underlying mechanism remains elusive.
Here, we studied the interaction between DM and DR3 in living cells by Fluorescence Resonance Energy Transfer (FRET). Applying CLSM-FRET microscopy allowed us to visualize these interactions at unprecedented resolution within MIIC of living cells. This interaction was not affected by neutralization of pH, and occurred exclusively in the internal structures of MIIC. No interaction was observed in MIIC devoid of internal structures after long-term chloroquine treatment or knockdown of hVPS34. Similarly, phagosomes in which many intracellular pathogens survive often lack internal membranes. This can occur when hVPS34 is inactivated (Vergne et al., 2003) , or when a downstream product of hVPS34 (PI(3,5)P2) is hydrolyzed by the Salmonella secreted PIP2-phosphatase SopB (Hernandez et al., 2004) . We show that at the limiting membrane of a Salmonella-induced phagosome (SCV) DM failed to interact with DR3, again using FRET. Consequently, DR3 was not loaded with antigens within the SCV while antigen loading within multivesicular MIIC continued in the infected cells. Local MHC class II-restricted immune escape of intracellular pathogens like Salmonella appears to be a consequence of subvesicular structural differences within the MIIC, where HLA-DM interacts with HLA-DR in MHC class II loading microdomains in the internal structures, but not at the limiting membrane.
Results

A system to monitor HLA-DR3 interaction with DM
To study the interaction between DR and DM, the molecules were tagged with two variants of the Green Fluorescent Protein, CFP attached to the cytoplasmic tail of DR3β and YFP linked to the cytoplasmic tail of DMα. GFP tagging of the DR3β chain has been successfully used before, without measurable effects on MHC class II behavior (Boes et al., 2002; Wubbolts et al., 1996) . The DMβ chain contains the lysosomal targeting information , therefore the DMα chain was used for YFP tagging. To investigate whether the various modifications still allowed a productive interaction between DR3/CFP and DM/YFP, the DRα and DR3β/CFP chains were stably expressed into Human Embryo Kidney (HEK) 293 cells along with the DMα/YFP and DMβ chains. We generated three cell lines: HEK293 cells expressing only DR3/CFP, HEK293 cells expressing DR3/CFP and DM/YFP, and HEK293 cells expressing DR3/ CFP, DM/YFP and the p30 form of the invariant chain (Ii). By introducing these chains in a non-immune cell line, DR3/CFP peptide loading could only be supported by YFP-tagged DM, since no endogenous DM was present. First, expression of the various subunits was confirmed by Western blotting (Fig 1A) . Subsequent analysis of the stable cell lines by Confocal Laser Scanning Microscopy (CLSM) revealed that DM/ YFP was efficiently targeted to endosomal structures, whereas DR3/CFP was mainly retained in the ER unless the invariant chain was co-expressed (suppl. Fig  S1) . In the presence of the invariant chain, DM/YFP and DR3/CFP were both efficiently transported to endosomal structures containing CD63 as a marker, and DR3/CFP arrived at the plasma membrane with similar efficiency as observed in cells endogenously expressing DR3 (Fig 1B and suppl. Fig S2) . These endosomal compartments had the characteristic morphology of MIIC and were a mixture of multilamellar and multivesicular bodies, as shown by immuno-electron microscopy (EM) (Fig 1C) . Note that DM/YFP and DR3/ CFP were both distributed over the limiting membrane and the internal vesicles of the MIIC.
Peptide loading was assayed biochemically. DR3 with high affinity peptides will not dissociate in SDS-loading buffer when incubated at room temperature, resulting in slower migration of the so-called compact form by SDS-PAGE analysis (Germain and Hendrix, 1991; Neefjes and Ploegh, 1992) . A substantial amount of compact DR3/CFP molecules was detected only when DM/YFP and the invariant chain were co-expressed (Fig 1D) . This was confirmed by surface iodination and analysis of DR3/CFP for tem-perature stability (Fig 1E) . DM/YFP supported peptide loading of DR3/CFP, implying that the CFP/YFPmodifications did not prevent a successful interaction between the two partners. Since the expression, distribution, MHC class II loading with peptides, and transport to the plasma membrane mimicked the situation in antigen presenting cells, we continued our studies with the HEK293 cells stably transfected with DR3/ CFP, DM/YFP and the invariant chain.
FRET analyses and the interaction of HLA-DM with HLA-DR3 or HLA-DO
FRET is the radiationless transfer of energy from an excited donor fluorophore to a suitable acceptor fluorophore, a physical process that depends on spectral overlap and proper dipole alignment of the two fluorophores. The occurrence of FRET between CFP and YFP is characterized by a decrease in CFP emission, and simultaneously sensitized (increased) YFP emission. Importantly, FRET is extremely sensitive to the distance between the fluorophores (its efficiency decays with the distance to the sixth power) (Förster, 1948) . For CFP and YFP, the characteristic half-maximum distance is 49-52Å (Förster radius), with an upper limit of ~80Å (Tsien, 1998) . Given the dimensions of GFP and its color variants (Ormo et al., 1996) , DM (Mosyak et al., 1998) and DR3 (Ghosh et al., 1995) , FRET between DR3/CFP and DM/YFP will only occur when both proteins are no more than one molecule in distance apart (Fig 2) . Thus, if FRET is observed, DM almost certainly interacts with DR3. FRET was studied by calculating the sensitized emission from confocal CFP and YFP images, as described in depth . Leakthrough factors (due to spectral overlap of the fluorophores) were calculated from cells expressing histon 2B (H2B) coupled to CFP or YFP that were co-cultured with the cells under study (see Methods and supplementary material) . No FRET signal of H2B-CFP and H2B-YFP should be observed in the final (fully corrected) sensi- Chapter 10 | HLA-DM/-DR interactions in vivo tized emission pictures. Fig 3A shows a representative example of our experimental procedure using CLSM-FRET. The H2B-C/YFP expressing control cells could be easily recognized by their nuclear fl uorescence. Sensitized emission (further referred to as 'FRET') between DM and DR3 was only detected in vesicles, as the algorithm used to correct for leakthrough terms effectively removed both the DR3 signal at the plasma membrane and the nuclear H2B-C/YFP fl uorescence ( Fig 3A, panel FRET) .
The effi ciency of DR3 interactions with DM was deduced from the donor FRET effi ciency (E D ), the FRET signal relative to the amount of donor fl uorescence, which is DR3/CFP. A donor FRET effi ciency of ~5.3% was detected, far above the minimal effi ciency detectable by this technique (see Methods). Little variation was observed between the various MIIC structures within one cell ( Fig 3A, panel E D ) , and in cells with different ratios of DR3/CFP versus DM/ YFP, suggesting saturating amounts of DM/YFP for the catalysis of peptide loading of DR3/CFP in these vesicles (suppl. Fig S3) . This was further visualized by plotting for each pixel the FRET effi ciency versus the DR3/CFP and DM/YFP intensities (Fig 3E) . No correlation was observed between FRET effi ciency and the intensity of CFP and YFP, showing that this represented true interactions rather than accidental collision of both proteins.
GFP and its color variants can be sensitive to environment, for example to hydrophobicity and pH (Tsien, 1998) . Since they are situated in acidic vesicles with many membranes, alterations in FRET could be the result of an altered environment in which the CFP/ YFP molecules reside. As a control, we generated a stable HEK293 cell line expressing DM/YFP and DO/ CFP. DO is homologous to DR (DOβ shares ~75% amino acid sequence identity with DR3β), but unlike DR interacts stably with DM. Consequently, if a change in FRET effi ciency between DO and DM is observed, this could be the result of an altered environment of the fl uorophores. DO is targeted mainly by DM to MIIC and is virtually absent from the plasma membrane. DO/CFP and DM/YFP localized to the same late endocytic, CD63-containing structures as DM/YFP and DR3/CFP, as shown by CLSM (Fig 3B) and immuno-EM with anti-GFP antibodies ( Fig 3C) . As observed before (van Lith et al., 2001) , DM/YFP, DO/CFP was mainly located on the limiting membrane but also on internal structures of characteristic multivesicular/ multilamellar MIIC. These DM/YFP, DO/CFP cells were used as controls in further experiments.
FRET was measured between DO and DM under conditions identical to those described for Fig  3A. Effi cient FRET was detected between these molecules (Fig 3D) . The FRET effi ciency for the interaction between DO and DM was 23.2% (S.D. 3.5%) compared to 5.3% (S.D. 1.5%) observed for DR3 and DM ( Fig  3F) , and is obviously not affected by acceptor (YFP) concentrations (Fig 3E) . This ratio in FRET effi ciency was determined by both wide fi eld (not shown) and CLSM-FRET, and confi rmed by FLIM (Fluorescence Lifetime Imaging Microscopy) analysis, an alternative technique to monitor FRET (Bastiaens and Squire, 1999) . The lifetime (the average duration of the excited state) for the donor CFP is typically 2.7ns , but is reduced when energy is transfered to YFP following the same rules for FRET as described earlier. FLIM offers the advantage that it reports FRET in a highly quantitative manner, but as implemented here, lacks confocal sectioning capacity. Also, it requires relatively long sampling times (~12s) to accurately determine the lifetime of the fl uorophore (a problem for moving vesicles). Fig 3G shows wide-fi eld FLIM measurements of the DM/YFP and DR3/CFP or DO/CFP cells, co-cultured with the H2B-CFP containing Mel JuSo cells in the presence of nocodazole to block vesicle transport. Arrows indicate examples of vesicles that were immobile during the measurement. The DR3/CFP lifetime was on average 2.49ns in the presence of DM/YFP, and 1.52ns in that of DO/CFP. These values correspond to a FRET effi ciency ratio of 1:5.6 ((2.7 -2.49) / (2.7 -1.52)), similar as detected with CLSM-FRET.
The higher FRET effi ciency between DM and DO is not surprising since these molecules continuously interact, whereas DM will interact transiently with DR3 as long as the class II molecule contains CLIP or another non-stably binding peptide. Together, these data show that we have established a cell system to follow interactions between DR3 and its dedicated chaperone DM in MIIC of living cells by FRET.
HLA-DR3 interactions with HLA-DM are not pH dependent in vivo unless HLA-DO is present
The interaction between DM and DR3 is sensitive to pH, at least in vitro. DM mediated peptide exchange on DR is optimal at pH 4.5 and about 4 times less efficient at pH 7 . Also, DM can only be co-isolated with DR at acidic pH . Furthermore, prolonged incubation with lysosomotropic agents like NH4Cl and chloroquine inhibits MHC class II antigen presentation Chapter 10 | HLA-DM/-DR interactions in vivo (Morrison et al., 1986) . We tested whether neutralization of MIIC by two minutes of chloroquine treatment (suppl. Fig S4) , affected the interaction between DM and DR3 in vivo in intact MIIC, as could now be visualized by FRET. The DM/YFP, DO/CFP cells were taken to control for potential influences of pH changes on the fluorophores. Neutralization of acidic structures did not affect FRET efficiency between DM and DO but, surprisingly, neither between DR3 and DM ( Fig  4A) . Only when the pH sensor DO (van Ham et al., 2000) was overexpressed in the DR3/CFP, DM/YFP cells (suppl. Fig S5) , a reduction in FRET efficiency between DR3 and DM was observed upon chloroquine treatment ( Fig 4B) . Overexpression of DO apparently does not change the relative orientation of DM to DR3, at least not at acidic pH, suggesting that DO does not act as a DR mimmick, but merely as a pH sensor for DM mediated peptide loading of DR . Still, there is an apparent discrepancy between the in vitro experiments where DR and DM require acidic pH for activity, and the in vivo FRET data. Possibly, DR3 and DM localize in microdomains within the MIIC that stabilize their interaction, even under conditions of neutral pH.
Spatial differences within MIIC affect HLA-DR3 interactions with HLA-DM
It has been known for over 20 years that longterm treatment with chloroquine or NH4Cl induces swelling of lysosomes (Ohkuma and Poole, 1981) . We demonstrate that the membranes needed for swelling are provided by internal vesicles that fuse back to the limiting membrane. This is concluded since 1. MIIC swelled after chloroquine treatment in our transfectants under conditions that vesicle transport was blocked (by destroying the microtubular network with nocoda- Figure 3A ). FRET between DR3/ CFP and DM/YFP is not affected by chloroquine treatment, and neither did neutralization affect DO and DM (n > 50 independent measurements). (B) The interaction between DR3/CFP and DM/YFP becomes pH dependent upon DO expression. The same analysis as in (A) was performed on the DR3/CFP, DM/YFP and invariant chain-expressing HEK293 transfectants (upper panel), and the same cells overexpressing unlabeled DO with H2B-mRFP as a transfection marker (lower panel). The H2B-mRFP signal is not shown (see Figure S5 ). Interaction between DR3/ CFP and DM/YFP is not affected by DO expression at normal acidic pH but is reduced upon neutralization with chloroquine. FRET efficie cies measured on the identical vesicles prior to and after neutralization are depicted in the bar diagrams with the SD indicated (n > 50 pairwise measurements). zole), and consequently input of new membrane material prevented (suppl. Fig S6 inset) . Membranes for the expanding limiting membrane can only be supplied by the internal structures under this condition. 2. Markers for internal vesicles like CD63 were found at the limiting membrane after long-term chloroquine treatment (data not shown). 3. EM showed that the swollen MIIC did not contain internal vesicles after 4-6h chloroquine treatment, as these had supplied the material for the expanding limiting membrane. Indeed, also DR3/CFP and DM/YFP were located at the limiting membrane by immuno-EM (Fig 5A) and CLSM ( Fig  5B) in structures without internal vesicles. Thus, longterm chloroquine treatment, which is known to prevent MHC class II antigen presentation, appears to alter the architecture of an MIIC structure by backfusion of the internal vesicles with the limiting membrane.
We made use of this MIIC remodeling in subsequent experiments where the interaction between DM and DR3 (and between DM and DO as a control) was measured in cells treated for 6h with 200 μM chloroquine (Fig 5B) . The interaction (as visualized by CLSM-FRET) between DM and DO was not affected on swollen late endosomal structures (middle panel), whereas DM and DR3 did not interact on the limiting membrane (the only membrane) of these structures (upper panel). The concentration of DR3/CFP and DM/ YFP does not decrease when the expansion of MIIC is the result of backfusion of internal structures. This implies that the FRET observed in Fig 3A and Fig 4A was Figure 3A ). The lower panel shows the E D in false colors projected on the CFP signal in white. Whereas DM and DO interact on the limiting membrane, no interaction is observed for DR3 and DM (n > 50 observations). (C) The structure of partially swollen MIIC after 3 hr chloroquine treatment. HEK293 cells expressing DR3/CFP, DM/YFP and Ii were cultured for 3 hr in the presence of chloroquine before analysis by cryo immuno-EM. Swollen MIIC are observed still containing internal structures. DR (15 nm gold) and DM (10 nm gold) are located on both the internal vesicles and limiting membrane. (D) DR3/CFP interacts with DM/YFP on the internal structures of MIIC. Living HEK293 cells transfected with DR3/CFP, DM/YFP, and Ii (upper panel) or DO/CFP, DM/YFP (middle panel) were analyzed by CLSM-FRET at 37°C after 3 hr of chloroquine treatment. Panels are organized identical as in (B). Whereas DM and DO interact on both the internal structures and the limiting membrane, DR3 and DM only interact on the internal structures (n > 100 observations).
not caused by coincidental collisions, but resulted from more stable interactions. This suggested that interactions between DR3 and DM in MIIC occur exclusively at the internal structures.
The size of MIIC (~500nm) is too small to distinguish between limiting and internal membranes by light microscopy. The swelling of MIIC by chloroquine occurs gradually. Therefore, we expected to obtain partially swollen structures with internal vesicles 2-3h after chloroquine addition, providing sufficient spatial resolution to distinguish internal and limiting membranes by CLSM-FRET. Immuno-EM 3h after chloroquine treatment showed swollen structures of around 1-2 μm with internal vesicles still containing DR3 and DM molecules (Fig 5C) . These MIIC were sufficiently large to resolve internal and limiting membranes by CLSM, and FRET between DR3/CFP and DM/YFP in the partially swollen MIIC was measured ( Fig 5D, upper panel) . Although DM and DR3 are both present on the limiting and internal membranes, a substantial interaction was only observed in the internal structures and not at the limiting membrane. To exclude a decrease in DM and/or DR3 concentration due to the addition of membranes derived from fused vesicles, we repeated the experiment on nocodazole treated cells. This gave identical results (suppl. Fig S6) . As a control, DM and DO showed FRET at both the limiting and internal membranes under identical conditions (Fig 5D, middle panel) . These data indicate that MIIC are not homogeneous structures, but that they contain various subdomains that allow a productive interaction between DM and DR3 only on the internal structures but not the limiting membrane.
Inhibition of formation of internal structures prevents the interaction between HLA-DR3 and HLA-DM.
The PI 3-kinase VPS34 is required to initiate a cascade of events resulting in recruitment of ES-CRT complexes, and ultimately formation of internal structures within multivesicular bodies (Katzmann et al., 2002) . Inhibition of hVPS34, either genetically or with chemical inhibitors (Fernandez-Borja et al., 1999) , results in swollen structures only containing a limiting membrane. Inhibition of hVPS34 would thus be an alternative to recruit DR3/CFP and DM/ YFP to the limiting membrane. However, unlike the situation for chloroquine, the structures remain acidic (suppl. Fig S7) . An RNAi construct targeting hVPS34 was co-transfected with mRFP in HEK293 cells expressing DR3/CFP, DM/YFP and the invariant chain, as well as in cells expressing DO/CFP, DM/YFP as a control. Only mRFP-positive cells were analyzed for swollen structures, and FRET and donor FRET efficiency were determined (Fig 6) . Whereas DM/YFP Figure 3A ). The lower panel shows the E D projected in false colors on the CFP signal in white. Whereas both DR3/CFP and DM/YFP are present at the limiting membrane of the expanded MIIC, they do not interact (n > 50 independent measurements). Chapter 10 | HLA-DM/-DR interactions in vivo and DO/CFP showed FRET with normal efficiency, no FRET was detected between DR/CFP and DM/YFP at the limiting membrane of these swollen structures, analogous to the situation where MIIC was expanded by chloroquine (Fig 6) . In conclusion, two treatments known to inhibit antigen presentation by MHC class II molecules (Allen and Unanue, 1984; Song et al., 1997) , also induce localization of DR3 and DM to the limiting membrane of MIIC, where the interaction between these two proteins is prevented.
HLA-DR3 interactions with HLA-DM and peptide loading on phagosomal membranes.
If DR3 and DM fail to interact efficiently on limiting membranes, this may explain examples of immune escape observed under physiological conditions. In particular, bacterial pathogens like Mycobacterium tuberculosis and Salmonella typhimurium survive and propagate in acidified, self-induced phagosomes often unnoticed by the immune system (Ramachandra et al., 2001) . Phagosomes contain a limiting membrane only, unless the pathogen is killed. Recently, it has been shown that Salmonella secretes the PIP2-phosphatase SopB into the cytoplasm of infected cells that hydrolyzes a downstream product of hVPS34 (PI(3,5)P2), thus inducing phagosome formation (Hernandez et al., 2004) . Hence, is the interaction between DR3 and DM inhibited at the phagosomal membrane? We infected HEK293 cells expressing DR3/CFP, DM/YFP and invariant chain with Salmonella for 4h and processed the cells for immuno-EM (Fig 7A, left panel) . Intracellular Salmonella was found in a typical phagosome (termed the Salmonella-containing vacuole or SCV), containing DR3 and DM at the limiting membrane. No internal vesicles were found, unless the bacterium was degraded (Fig 7A, right panel) . Conventional, unaffected MIIC were also found in the same cell (Fig 7A,  left panel insert) . Next, we determined whether FRET between DR3/CFP and DM/YFP could be detected in SCV. As a control, we measured FRET between DM/ YFP and DO/CFP on the same compartment. To allow simultaneous visualization of the intracellular bacteria, we generated mRFP-expressing Salmonellae. Fig  7B shows CLSM-FRET images of SCV and MIIC after 4h Salmonella infection in cells expressing DM and DO. The interaction between DO/CFP and DM/ YFP was not affected on the phagosomal membrane. The interaction of DM and DR3 on SCV is shown in Fig 7C. To exclude the possibility that FRET between DR3/CFP and DM/YFP was not observed because their fluorescent intensities fell below the treshold set for background fluorescence, we analyzed the data in Fig 7B and 7C by the same 2D intensity plot approach used in Fig 3E. In addition, the CFP and YFP intensities of the pixels corresponding to the limiting membrane of the SCV where FRET was not detected are indicated in purple (Fig 7D) . The limiting membrane of SCV contained hardly any pixels without FRET between DO/CFP and DM/YFP (resulting in only few purple dots in the middle panel). In contrast, pixels lacking FRET efficiency at the SCV membrane were abundantly found in the DR3/CFP, DM/YFP cells. The intensities of CFP and YFP in the majority of these SCV pixels corresponded to those found for MIIC in the same cell with positive FRET efficiencies. This analysis was repeated by considering the poisson distributed noise for the calculated E D per pixel (suppl. Fig S8) . Collectively, these data show an equally efficient interaction between DO and DM in MIIC and SCV, whereas the interaction between DR3 and DM was only observed in the MIIC and not the SCV membrane. Thus, within the same cell, two types of MHC class II containing compartments were found: MIIC, where DM and DR3 could engage in antigen loading, and SCV, where DM and DR3 were prevented from interacting. MIIC vesicles showed continuous kiss and run type of contacts with the SCV (data not shown), but no DM/DR3 interaction was observed on the limiting membrane in more than 60% of the SCV (41 negative, 25 positive SCVs, n=66). When Salmonella was intracellularly degraded, internal structures re-appeared (Fig 7A, right panel) , probably leading to some SCVs with detectable FRET between DM and DR3. Thus, the interaction between DR3 and DM was obstructed in intact phagosomal structures, similar to the situation in swollen MIIC, apparently because the micro-environment of internal endosomal membranes is a prerequisite for this interaction.
Is the loading of MHC class II molecules in SCV affected, as would be predicted from the FRET data? HEK293 cells expressing DR3/CFP, DM/YFP and the invariant chain were infected with Salmonella for 4h before subcellular fractionation. 20% of each fraction was used to measure β-hexosaminidase activity to position the late endosomes and lysosomes (Fig 7E, upper panel) . The rest was incubated in SDSsample buffer at room temperature before separation by SDS-PAGE and Western blotting. This procedure should allow detection of compact type, SDS-stable, peptide-loaded DR3/CFP molecules (Germain and Hendrix, 1991) . The nitrocellulose filter was probed sequentially with antibodies directed against the DRα chain and DR3αβ-peptide complex, against GFP, MHC class I molecules, and against a 30kD Salmonella protein. The position of the various proteins is given in the compilation (Fig 7E, lower panel) . MHC class I marks the plasma membrane and ER (fraction 6,7), β-hexosaminidase and DMα-YFP the MIIC (fractions 5,6), and the Salmonella protein the SCV (fractions 9,10). SCV contained both DM/YFP and DR3/CFP, as Article was also shown by CLSM and EM (Fig 7A-C) . Still, whereas a large portion of DR3/CFP was in a compact state in the plasma membrane and MIIC-containing fractions, hardly any peptide-loaded DR3 molecules were observed in SCV (compare lanes 5 and 9 figure  7E ). Peptide loading of DR3 in SCV was apparently very inefficient, corresponding with the poor interaction observed between DM and DR3 on the limiting membranes of SCV and MIIC.
Discussion
The MIIC was defined in 1991 as a late endosomal compartment with a multilamellar morphology containing MHC class II molecules (Peters et al., 1991) . Since then, a number of factors have been defined, notably cathepsins (Honey and Rudensky, 2003) and DM (Denzin and Cresswell, 1995; Sherman et al., 1995) , required for successful antigen loading of MHC class II molecules. The localization of DM to MIIC, defined it as the major site for antigen loading of MHC class II molecules (Sanderson et al., 1994) . The interaction between DM and MHC class II molecules has been shown in vitro and by co-isolation (Doebele et al., 2000; Ullrich et al., 1997) . Critical for this interaction is acidic pH, as expected for a late endosomal chaperone. How DM and DR interact in living cells has been unclear. For this reason, we generated cells expressing DR3 conjugated to CFP and YFP-labeled DM. DR3/CFP required the invariant chain for efficient release from the ER and transport to MIIC. The CFP/YFP modifications did not block peptide loading of DR3 since compact, SDS-stable, DR3/ CFP molecules were formed with the support of DM/ YFP. Next, we studied the interaction between DR3 and DM in living cells by FRET analysis. As a control, we used a cell line expressing DM/YFP and DO/CFP. DO is very similar to DR3, but stably interacts with DM. Because of their high similarity, DO may mimic DR for DM molecules. However, since overexpressed DO does not affect the FRET efficiency between DR3 and DM, this is unlikely. DO is apparently not a competitor for DR3 binding to DM but probably binds at another site thus affecting the (pH-dependent) chaperoning activity of DM.
The internal membranes of the MIIC have a different protein and lipid composition than the limiting membrane. DM and DR can be found in both endosomal subcompartments, albeit in variable amounts (Kleijmeer et al., 1997) . We have investigated DR/DM interactions in the MIIC by FRET. Like their untagged counterparts, the DR3/CFP and DM/YFP molecules localized to both the internal structures and the limiting membrane, but FRET between these molecules was only seen on the internal structures. In order to optically separate internal and limiting membranes, the MIIC was swollen by chloroquine treatment. Chloroquine induces the fusion of internal structures with the limiting membrane, which subsequently expands at the cost of the internal structures. Long-term treatment with chloroquine completely depleted the internal structures and DR3 and DM resided at the limiting membrane where they failed to interact. Chloroquine treatment is a common way to inhibit (most) MHC class II responses. This could be the result of decreased antigen degradation by lysosomal proteases due to neutralization (although most cathepsins are active at neutral pH), less efficient support by DM (yet we show that the interaction with DR3 is not disturbed by neutralization), but may also be the result of repositioning DM and DR3 to the limiting membrane where they do not interact.
How is the interaction between DM and DR3 supported at the internal structures? Obvious candidates are the tetraspans CD63 and CD82, given their almost exclusive location in the internal structures and their interaction with MHC class II and DM (Escola et al., 1998; Hammond et al., 1998) . It has been suggested that microdomain clusters of DR/DM and the tetraspans could have different peptide loading properties (Kropshofer et al., 2002) . However, the tetraspans CD63 and CD82 are also relocated to the limiting membrane following chloroquine treatment (not shown) where DR3 and DM do not interact. Thus, the tetraspans CD63 and CD82 are not sufficient, if at all required, for stable DR3/DM interactions. Whether other proteins or lipids are involved in the formation of a putative 'MHC class II loading microdomain' inside the MIIC, is as yet unclear.
Phagosomes are endosomal structures where intracellular bacteria survive and even propagate. Morphologically, these structures resemble a swollen MIIC, and can be considered a limiting membrane around the bacterium. Various studies describe the effect of intracellular bacteria on antigen presentation. CD4+ T cells can be easily isolated after most bacterial infections, but it is unclear whether this is a response to a killed bacterium or a viable one. In vitro T cell assays yield mixed conclusions (Zur Lage et al., 2003) . T cell responses against other antigens co-incubated with the bacterium are usually not affected, although some infections can reduce or inhibit antigen presentation by MHC class II (Flynn and Chan, 2003) . Whereas various bacteria neutralize phagosomes, Salmonella allows acidification, which is even required for the secretion of effector proteins (Beuzon et al., 1999) . Salmonella apparently forms phagosomes by secreting a PIP2-phosphatase, SopB, thus inactivating the hVPS34-ES-CRT system of internal vesicle formation (Hernandez et al., 2004) . Likewise, M. tuberculosis toxin directly inactivates hVPS34 (Vergne et al., 2003) . Downregula-
Immunity
Chapter 10 | HLA-DM/-DR interactions in vivo tion of hVPS34 by RNAi induced expanded MIIC and prevented the interaction between DR3/CFP and DM/ YFP on the limiting membrane. This also inhibits antigen presentation by MHC Class II (Song et al., 1997) . In addition, the expression of DM/YFP and DR3/CFP at the SCV was lower. Whether this is the consequence of the altered interactions is unclear.
Still, the effect on DM/DR interactions is local. In the same cells, 'normal' MIIC were found where DM and DR3 associated both in biochemical and FRET assays. Fractionation studies indicated that MHC class II loading occurs in MIIC structures, but poorly in SCV. This suggests that intracellularly growing bacteria prevent local MHC class II presentation by preventing the formation of the typical architecture found in MIIC. At present, it is unclear whether this is just the result of their physical size or a situation actively maintained by the bacterium. In approximately 35% of the cases, we detected FRET between DM and DR3 in Salmonella containing phagosomes, which could be the result of death and disintegration of the bacterium; conditions where internal DM and DR3 containing structures reappear in the SCV. However, surviving and viable intracellular pathogens will remain undetected by CD4+ T cells as long as they prevent leakage of antigens into conventional MIIC. This local immune evasion may explain why other antigen presenting molecules have been developed, the CD1 family, to present antigens in a manner independent of DM (Vincent et al., 2003) .
We have visualized the interaction of DM and DR3 in living cells by FRET and have defined an MHC class II loading microdomain. DR3 interacted with its chaperone DM only on the internal membranes within an MIIC. Consequently, structures containing only a limiting membrane will not support efficient interactions between these two molecules, a situation observed in phagosomes. By preventing the formation of the conventional architecture of MIIC, Salmonella excludes the creation of 'MHC class II loading microdomains', resulting in ineffective antigen presentation by MHC class II molecules.
Methods are described in the Supplementary section.
Supplemental Data
Supplemental Experimental Procedures
Antibodies and Fluorophores
The following antibodies were used. Mouse monoclonal antibodies HC-10 (class I Heavy Chain) (Stam et al.,1986) ; anti-CD63 (NKI-C3) (Vennegoor and Rumke, 1986) ; HLA-DR-specific mAbs 1B5 (Adams et al., 1983) and Tü36 (Shaw et al., 1985) , and the HLA-DMα-specific mAb 5C1 . Rabbit polyclonal sera anti-DR (Neefjes et al., 1990) , anti-GFP, anti-Salmonella (Salmonella 30 kDa) and rabbit anti-DOβ serum , and the Ii-specific polyclonal serum ICN2 (Morton et al., 1995) have previously been described. The Cy5 and horseradish peroxidase-conjugated secondary antibodies were from Sigma-Aldrich co. (Steinheim, Germany). Fluorescent secondary antibodies were from Molecular Probes (Leiden, The Netherlands).
DNA Constructs and the Generation of Transfectants
Constructing pcDNA3.1 Zeo DMβ-IRES-DMα/YFP A fusion construct between YFP and the C terminus of DMα was generated by PCR. pcDNA3.1 Zeo vector (Invitrogen) was digested with BamHI and EcoRI and ligated to an IRES sequence, digested with BamHI and EcoRI, forming IRES pcDNA3.1 Zeo. IRES pcD-NA3.1 Zeo was subsequently digested with EcoRI and XhoI. The digest was ligated with DMα-YFP, digested with EcoRI and XhoI, forming pcDNA3.1 Zeo IRES DMαYFP. pcDNA3.1 Zeo-IRES-DMα/YFP was subsequently digested with NheI and NotI and ligated with DMβ (Copier et al., 1996) , digested with NheI and NotI in presence of 0.5% BSA, forming pcDNA3.1 Zeo-DMβ-IRES-DMαYFP.
Constructing pCEP4Δ DOα−IRES-DOßCFP
Generation of a fusion construct between CFP and the C terminus of DOβ (Copier et al., 1996) was achieved via PCR. pCEP4Δ vector was digested with KpnI and HindIII. The digest was ligated with DOα , digested with KpnI and HindIII, forming pCEP4Δ DOα This construct was subsequently digested with EcoRV and NheI and ligated with IRES sequence, digested with EcoRV and NheI. Next, pCEP4Δ DOα-IRES was digested with NheI and XhoI and ligated with DOßCFP, digested with NheI and XhoI, forming pCEP4Δ DOα-IRES-DOßCFP. The same construct was generated without CFP attached to DOβ for use in HLA-DO overexpression experiments.
Constructing pcDNA3 DRα-IRES-DR3β/CFP
The fusion construct between CFP and the C terminus of DR3β was generated via PCR. pcDNA3 DOβ/ GFP vector was digested with HindIII and BamHI and ligated with DR3β, digested with HindIII and BamHI, forming pcDNA3 DOα-GFP/DR3β. Subsequently, pcDNA3 DOα-GFP/DR3β was digested with BamHI and EcoRI and ligated with IRES, digested with EcoRV and NheI, forming pcDNA3 DRα-IRES. pcDNA3 DRα-IRES was subsequently digested with EcoRI and XhoI and ligated with DR3βCFP, digested with EcoRI and XhoI in Buffer H, forming pcDNA3 DRα-IRES-DR3β/CFP. Constructing PSV51Ii, pcDNA3-H2B/CFP and -H2B/ YFP P30 invariant chain fragment was cut (EcoRI-Bam-HI) from Gem4sp6Ii vector and ligated blunt into the SmaI site of the PSV51L vector (gift from O.Bakke, Oslo). For selection, PSV51LIi was cotransfected with pcDNA3 ouabaine vector . GFP was swapped for CFP or YFP in H2B-GFP cloned in Article pcDNA3 (Kanda et al., 1998) 
Constructing pSUPER-hVPS34
To generate the RNAi construct targeting the PIK3C3 gene (hVPS34), the RNAi vector pSUPER (Brummelkamp et al., 2002) was digested with BglII and HindIII and the annealed oligos containing the sequence AGTAGATTGGCTGGATAGA specific for hVPS34 were ligated into the vector.
Constructing mRFP-expressing Salmonella Salmonella typhimurium strain SL1344 was transformed with a bacterial expression vector for mRFP (kind gift of R. Tsien). mRFP expressing bacteria were selected by fluorescence microscopy and further purified before use in tissue culture FRET experiments. All DNA manipulations were performed using standard procedures, and verified by sequencing.
Human Embryo Kidney (HEK) 293 cells were stably transfected with DOαIRESDOβ/CFP, DRα-IRESDR3β/CFP, DMβ-IRES-DMα/YFP, p30 invariant chain and/or pcDNA3 Ouabaine vector or left untransfected. These cells were grown on Dulbecco's modified Eagle's medium (DMEM) supplemented with 7.5% fetal calf serum (Gibco, Paisley, UK) in the presence or absence of 1000 μg/ml G418, 300μg/ml Hygromycin (Gibco, Paisley, UK), 500 μg/ml Zeocine (Invitrogen, Carlsbad, USA) and/or 2μM Ouabaine (Invitrogen, Carlsbad, USA), at 37°C in a humidified atmosphere containing 5% CO2. Stable expression of the CFP-and YFP-tagged proteins was ensured by regular selection of the CFP-and YFP-positive cells by FACS sorting. Stable transfectants of the melanoma cell line Mel JuSo (H2B-CFP, H2B-YFP) were grown in Iscove's medium with 7.5% FCS supplemented with 1000 μg/ml G418. For the HLA-DO competition experiments, 293 cells stably expressing HLA-DR3/CFP, HLA-DM/YFP and invariant chain were transiently transfected with DOαIRESDOβ and an empty vector mRFP vector (in 50:1 molar ratio) and analyzed 48 hr after transfection.
Biochemical and Western Blot Analyses
Cell surface protein labeling was performed by lactoperoxidase-catalyzed iodination with 1mCi Na125I on cells grown to subconfluency in a 75-cm2 tissue culture flask. Cells were washed four times with cold PBS, lysed in Tris-lysis buffer (pH 7.4) containing 0.5% NP-40 and 5mM MgCl2, and used for immunoprecipitations with antibody recognizing MHC ClassII αβ complexes (Tü36). Samples were analyzed by 10% SDS-PAGE. Total protein expression levels were analyzed by growing HEK293 cells, stably transfected with HLADR3/CFP, HLA-DM/YFP,-DR/CFP, HLA-DM/YFP,-DR/CFP and Ii, HLA-DM/YFP,-DO/ CFP or left untransfected, to subconfluency in Ø 10cm dishes. Cells were washed four times with cold PBS, lysed in Tris lysis buffer (pH 7.4) containing 0.5% NP-40, 50mM Tris-HCl pH 7.4 and 5mM MgCl2. Lysates were split into two halves. One was incubated in SDS-sample buffer at 95°C for 5 min, the other left at room temperature. Samples were separated by 10% SDS-PAGE, transferred to nitrocellulose and immunolabeled with antibodies against GFP, HLA-DM, -DR, and -DO. To test for stability of the class II complex, boiled and unboiled samples were separated by 10% SDS-PAGE, transferred to nitrocellulose and incubated with antibody recognizing the DRα chain, both in the stable class II complex and as a free α chain (1B5). Equal amounts of protein were loaded.
CLSM and Immuno-Electronmicroscopy Analysis
For CLSM analysis, coverslips were coated with 5μg/ml fibronectin (Sigma-Aldrich co., Steinheim, Germany) in PBS for 1h at 37°C. Subsequently, HEK293 transfectants were seeded on the coated coverslips. These were fixed with methanol and stained with anti-CD63 antibodies NKI-C3, and secondary antibodies conjugated to Cy5. Images were taken with a Leica TCS SP2 System (Leica, Mannheim, Germany). HEK293 transfectants were fixed in a mixture of paraformaldehyde (4%) and glutaraldehyde (0.5%) prior to processing for immuno-electronmicroscopy. Cells were incubated with 200μM chloroquine for 3h or 6h before processing. For the Salmonella infection, Salmonella strain SL1344 was cultured o/n followed by renewed culture for 3h. For immuno-labeling, sections were incubated with purified mAb anti-human DMα (5C1), followed by incubations with rabbit anti-mouse IgG and 10nm protein A-conjugated colloidal gold. Subsequently, the sections were treated with 1% gluteraldehyde, followed by another incubation with rabbit anti-human class II serum and 15nm protein A-conjugated colloidal gold. After embedding in a mixture of methyl-cellulose and uranyl acetate, sections were analyzed with a Philips CM10 electron microscope (Eindhoven, the Netherlands).
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Confocal FRET (CLSM-FRET) Imaging by Sensitized Emission
The HEK293 transfectants were grown on the coated coverslips for 72h before imaging. 24h prior to imaging, Mel JuSo cells, stably transfected with H2B-CFP or H2B-YFP were added to the culture. Prior to CLSM, culture medium was changed for 2ml CBS medium (140mM NaCl, 5mM KCl2, 2mM MgCl2, 1mM CaCl2, 23mM NaHCO3, 10mM D-Glucose, 10mM Hepes pH 7.3) under 5% CO2, and the coverslips were analyzed in a heated tissue culture chamber at 37°C. Where indicated, chloroquine was added at a final concentration of 200μM for 2.5-3h or 6h prior to analysis. In the shortterm pH neutralization experiments, the same cell was analyzed prior to and directly after a 2′ chloroquine treatment. For the RNAi experiments, cells were transfected with the pSUPER construct targeting hVPS34 and an empty mRFP vector as a transfection marker in a 10:1 ratio. 72h after transfection, mRFP positive cells were analyzed. Fluorescence Resonance Energy Transfer between CFP and YFP molecules was studied by calculating the sensitized emission (the YFP emission upon CFP excitation) from separately acquired donor and acceptor images. Images were acquired on a DM-Ire2 inverted microscope fitted with TCS-SP2 scanhead (Leica, Mannheim, Germany). Three images were collected: CFP excited at 430nm and detected between 470 and 490 nm; indirect YFP: excited at 430nm and detected between 528 and 603nm; and direct YFP excited at 514nm, and detected between 528 and 603nm. When simultaneously mRFP-Salmonella was monitored, CFP emission was detected between 455 and 510nm for noise reduction, and YFP emission was detected between 525 and 550 nm to minimize leakage of mRFP signal into the YFP channel. mRFP was excited at 568nm, and detected between 582nm and 675nm. Remaining mRFP bleedthrough was eliminated by masking all pixels in the CFP, indirect YFP, and direct YFP images that corresponded to mRFP-positive pixels in the image taken of the mRFPSalmonellae. Because of considerable overlap of CFP and YFP spectra, YFP emission was corrected for leakthrough of CFP emission and for direct excitation of YFP during CFP excitation. FRET was calculated from these data as described in detail . In brief, the images were shade-corrected and optionally smoothed. Sensitized emission (F Sen ) was calculated using correction factors obtained from cells expressing either CFP or YFP alone, which were updated for every image. Then the apparent FRET efficiency was calculated by relating the F Sen to the total donor level (E D ). See supplementary information for more details. Given the microscope used, the fluorescence intensities measured, and the number of pixels analyzed, FRET efficiencies as low as ~0.5% can be measured reliably (K.J. unpublished observations). Resulting FRET efficiency images were analyzed by plotting the CFP and YFP intensities for all pixels in a 2D plot, with the corresponding FRET efficiency in false colors. Using MatLab7 software (The Mathworks, Natick, USA) a mask was generated to select all pixels above the threshold set for both the CFP and YFP intensities (to exclude background fluorescence). For each pixel the CFP, YFP and FRET efficiency values were extracted and plotted using pro Fit 6 software (Quansoft, Uetikon am See, Switzerland). In case of the Salmonella experiments, pixels representing the SCV were extracted that 1) were contained within a region of interest drawn around the bacterium, 2) had intensities of both CFP and YFP that were above the set treshold to exclude background fluorescence, and 3) had a FRET efficiency of 0. Also for these pixels, the CFP and YFP values were extracted and plotted. For the E D histograms shown in Fig S8, all pixels of an MIIC and SCV with a donor or acceptor fluorescent intensity between 10 and 250 were considered. Donor FRET efficiencies of these pixels were binned in 30 categories from -0.75 to +0.75 and plotted in a histogram.
Fluorescence Lifetime-Imaging Microscopy
Fluorescence Lifetime-Imaging (FLIM) experiments were performed on a Leica inverted DM-IRE2 microscope equiped with a Lambert Instruments frequency domain lifetime attachment (Leutingewolde, The Netherlands), controlled by the vendors EZflim software. CFP was excited at 430nm with ~4mW power using a LED modulated at 40MHz. Emission was collected at 450-490nm using an intensified CCD camera. Calculated CFP lifetimes were referenced to a 1 μM solution of Rhodamine-G6 in medium that was set at 4.11ns lifetime, and calibrated using co-expressed H2B-CFP containing cells for which the lifetime was set to 2.7ns .
Subcellular Fractionation
HEK293 transfectants were infected with Salmonella for 4h. Cells were washed with PBS and scraped from the plate prior to dounching by an EMBL Cell Cracker. Debris was removed by a low spin centrifugation step and the post-nuclear supernatant was loaded on a 0.4-2.4M step-wise sucrose gradient (steps of 0.4M) in 10μM Tris-HCl pH8.0. This was centrifuged for 3h in a swing-out rotor (Beckman 40.1Ti) at 28.000 rpm. 0.5ml samples from the gradient were diluted 1:1 with PBS and 200μl was used in a standard β-hexosaminidase assay. The rest of the vesicles was pelleted by cen-trifugation (15 min, 12.000g), and incubated in SDSloading buffer for 5 min at room temperature prior to separation by 10% SDS-PAGE and Western blotting.
Information on FRET Calculations
For more details on FRET Calculations, see . FRET between CFP and YFP can be studied by calculating the sensitized emission (F Sen ), the acceptor emission upon donor excitation, from separately acquired CFP and YFP images. CFP and YFP have a spectral overlap. Therefore, the detected sensitized emission must be corrected for CFP leakthrough into the acceptor channel and direct excitation of YFP during CFP excitation to obtain the measured sensitized emission (M Sen ). Consequently, three images were acquired, MCFP; CFP excitation, and CFP detection, M IndirectYFP ; CFP excitation and YFP detection, M DirectYFP ; YFP excitation and YFP detection. From the M IndYFP image, sensitized emission was calculated using the following equation: 
where Q CFP and QYFP are the quantum yield of respectively CFP and YFP, C is the fraction of CFP spectrum in the YFP channel, D the fraction of YFP spectrum in the YFP channel and ζ is a constant which can be derived from: ζ =(δβ-((CQ CFP /DQ YFP )/(1-βδ))).
To reliably calculate sensitized emission, corrections should be performed on major sources of error and variability in confocal acquisition of M CFP , M IndirectYFP and M DirectYFP images. Since different laser lines are used to excite CFP and YFP (430nm for MCFP and MIndirectYFP and 514 nm for MDirectYFP), chromatic aberrations within the objective and other optics, and small collimation differences in the laser beams result in an axial offset in the optical section of the acquired CFP and YFP images. To correct for this, M CFP and M IndirectYFP images were acquired using 430nm excitation (optimal excitation for measuring FRET). Then, using the Z-galvanometer of the microscope stage, the preparation is refocused to minimize the axial offset where after the M DirectYFP image is acquired using 514nm excitation. After image acquisition, images were corrected for lateral image errors. The excitation intensity varies within an image (most apparent at the borders of an image), especially in confocal acquisition since the different excitation sources give different excitation intensity distributions. Because these excitation inhomogeneities are constant over time, they were corrected by normalizing the acquired images by reference images (e.g. images of CFP and YFP solutions). The excitation intensity not only varies laterally, but temporally as well, which makes the calculation of sensitized emission extremely difficult, since the correction factors α and γ will change in time. To correct for this, for every pair of images acquired, new control cells were imaged to reliably recalculate the correction factors. For exact details, see van Rheenen and coworkers (2004) . Of note: parts of these algorithms will be implemented in new software commercially available from Leica Microsystems AG. Figure 3A) . FRET efficiency between DR3/CFP and DM/YFP is not affected by varying levels of donor DR3/CFP molecules, suggesting saturating amounts of DM/YFP in these vesicles. (B) The interaction between DR3/CFP and DM/YFP was measured by confocal-FRET on stable HEK293 transfectants transiently overexpressing DM/YFP (marked with an asterix). The CFP signal, YFP signal, FRET and donor FRET efficiency (E D ) measurements are depicted. FRET efficiency between DR3/CFP and DM/YFP is not altered by the increasing levels of acceptor DM/YFP molecules.
Article Figure S5 . HLA-DO Overexpression in Fixed Cells HEK293 cells stably expressing DR3/CFP and DM/YFP, and overexpressing unlabeled DO and H2B-mRFP as an transfection marker, were fi xed with formaldehyde and stained with anti-DOβ antibody . Cells expressing nuclear mRFP also contain DO, which colocalizes with DM/YFP and DR/CFP in perinuclear vesicles. 
